Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99644613 | 9964461 | 3 | F | 20160722 | 20140305 | 20160722 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-20339826 | BRISTOL MYERS SQUIBB | 0.00 | F | Y | 0.00000 | 20160722 | OT | FR | SN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99644613 | 9964461 | 1 | PS | EFAVIRENZ | EFAVIRENZ | 1 | Oral | 600 MG, QD | 20972 | 600 | MG | CAPSULE, HARD | QD | ||||||
| 99644613 | 9964461 | 2 | SS | EFAVIRENZ | EFAVIRENZ | 1 | Oral | 800 MG, QD | 20972 | 800 | MG | CAPSULE, HARD | QD | ||||||
| 99644613 | 9964461 | 3 | SS | TENOFOVIR | TENOFOVIR | 1 | Oral | 245 MG, QD | U | 0 | 245 | MG | QD | ||||||
| 99644613 | 9964461 | 4 | SS | EMTRICITABINE | EMTRICITABINE | 1 | Oral | 200 MG, QD | U | 0 | 200 | MG | QD | ||||||
| 99644613 | 9964461 | 5 | SS | NEVIRAPINE. | NEVIRAPINE | 1 | Unknown | U | 0 | ||||||||||
| 99644613 | 9964461 | 6 | C | RIFAMPIN. | RIFAMPIN | 1 | Unknown | U | 0 | ||||||||||
| 99644613 | 9964461 | 7 | C | SULFAMETHOXAZOLE-TRIMETHOPRIM (SMZ) | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 99644613 | 9964461 | 1 | HIV infection |
| 99644613 | 9964461 | 3 | HIV infection |
| 99644613 | 9964461 | 4 | HIV infection |
| 99644613 | 9964461 | 5 | HIV infection |
| 99644613 | 9964461 | 6 | Product used for unknown indication |
| 99644613 | 9964461 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 99644613 | 9964461 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 99644613 | 9964461 | Maternal exposure during pregnancy | |
| 99644613 | 9964461 | Stillbirth |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |